PCNX expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.25970378362217E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.42040000048216E-07 |
Normal-vs-Stage2 |
1.2793000000455E-06 |
Normal-vs-Stage3 |
1.17683640610267E-14 |
Normal-vs-Stage4 |
1.123850E-03 |
Stage1-vs-Stage2 |
7.310500E-02 |
Stage1-vs-Stage3 |
3.71009999999838E-06 |
Stage1-vs-Stage4 |
2.296800E-01 |
Stage2-vs-Stage3 |
1.604800E-01 |
Stage2-vs-Stage4 |
8.843400E-01 |
Stage3-vs-Stage4 |
5.053800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.41949843177758E-11 |
Normal-vs-AfricanAmerican |
1.66739999996057E-06 |
Normal-vs-Asian |
1.006240E-01 |
Caucasian-vs-AfricanAmerican |
9.395400E-01 |
Caucasian-vs-Asian |
5.557600E-01 |
AfricanAmerican-vs-Asian |
4.674800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.06380517914818E-11 |
Normal-vs-Female |
3.29929999987044E-08 |
Male-vs-Female |
1.563580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.67029999995372E-06 |
Normal-vs-Age(41-60Yrs) |
2.02910000000056E-05 |
Normal-vs-Age(61-80Yrs) |
4.05064870534488E-12 |
Normal-vs-Age(81-100Yrs) |
8.51460002504467E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.073000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.552600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.845170E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.235800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.863400E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.276400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.159200E-01 |
Normal-vs-Grade 2 |
1.57030000003111E-06 |
Normal-vs-Grade 3 |
1.62547753035369E-12 |
Normal-vs-Grade 4 |
1.241160E-03 |
Grade 1-vs-Grade 2 |
6.442200E-02 |
Grade 1-vs-Grade 3 |
8.39370000000894E-05 |
Grade 1-vs-Grade 4 |
1.170250E-02 |
Grade 2-vs-Grade 3 |
1.50955000000064E-05 |
Grade 2-vs-Grade 4 |
1.736640E-01 |
Grade 3-vs-Grade 4 |
9.011600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.39050000003138E-06 |
Normal-vs-ccB subtype |
2.40341080370854E-12 |
ccA subtype-vs-ccB subtype |
1.418700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.36740000053781E-07 |
Normal-vs-N1 |
5.32699999999942E-07 |
N0-vs-N1 |
6.486100E-02 |
|
|